Acknowledging the kind of traction gained by this market, recently published a study report by industry data analytics asserts the Global OTC Probiotics Supplement size is projected to accrue voluminously by 2027 registering a phenomenal CAGR of 8.35% during the review period (2022 to 2027).
The global OTC Probiotics Supplement market size was valued at USD 4.0 billion in 2020. The increase in the demand for quality products compliant with regulatory standards joined with the technical and financial benefits of these skills is helping businesses achieve superior position. Moreover, benefits such as customized solutions, reduction in time and cost, and development of the product flow amid cleanrooms are among key factors boosting the demand. Technological advancements associated with these technologies, from HEPA technology to the unidirectional airflow system, to the commercialization of these technologies to linked OTC Probiotics Supplement, are other factors expected to boost the shop for OTC Probiotics Supplement over the estimate period.
The Global OTC Probiotics Supplement includes identification and analysis of the various market participants competing in the global market. Prime competitors include Probiotics Market Are Chr. Hansen Holding A/S,Biogaia Ab,,Probi Ab,Nestlés.A.,Dowdupont Inc., The Procter & Gamble Company,Probiotics International Limited,Lallemand Inc. Pfizer Inc.,Pharmacare Laboratories,,.Dr. Willmar Schwgroup,Symbiopharm Gmbh,, Dupont,Danone,Probi Ab, Lifeway Foods, Inc.,Kibow Biotech,Pharmavite Llc,Osmotica Pharmaceuticals Corp,Dietary Pros, Inc.,Royal Dsm And, Others
May 10, 2022: Lifeway Foods, Inc. (Nasdaq: LWAY) ("Lifeway" or "the Company"), the leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, continues to stand with the people of Ukraine by expanding humanitarian relief efforts to support those in need. Building on the Company's ongoing efforts, Lifeway will release a specially marked charity relief bottle with 100% of profits going toward Ukrainian humanitarian aid with a commitment of up to $1 million.
Apr 13, 2021: Kibow Biotech, Inc., a clinical-stage biotechnology company pioneering the discovery and development of probiotics and prebiotics for the treatment of kidney diseases beyond gut health, has announced that the U.S. Food and Drug Administration (FDA) had approved the Company's Investigational New Drug Application (IND) for US-APR2020 to treat patients with chronic kidney disease (CKD) stage IV.
Market is segmented based on the type, applications, companies and regions.
By Types, it is segmented into
By End -user, it is segmented into
North America emerged as one of the most protuberant local markets accountings for a revenue share of 39% in 2020. North America has a massive population facing rising cases of obesity and digestive distress on account of their nutritional habits. As per GI Alliance, about 62 million American populace is diagnosed with a digestive disorder yearly. Thus, the rising prevalence of digestive diseases is expected to fuel probiotics demand.
Europe is predictable to grow at a significant CAGR of 6.3% over the forecast period owing to the rising adoption of addition products. For instance, as per Synadiet Survey 2020, about 36% of the surveyed population in France consumed food supplements and natural health products to boost immunity after the emergence of COVID-19. The survey stated that after the first upsurge of COVID-19 infection, about 17.0% of the surveyed population used probiotic supplements
The Global OTC Probiotics Supplement describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global OTC Probiotics Supplement report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
Report Attributes | Report Details |
Forecast Period 2022 to 2028 CAGR | CAGR of 8.35% during the review period (2022 to 2027). |
By Form -outlook |
|
By End-user |
|
By Companies | Probiotics Market Are Chr. Hansen Holding A/S,Biogaia Ab,,Probi Ab,Nestlés.A.,Dowdupont Inc |
Regions Covered |
|
Countries Covered |
|
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2022 to 2027 |
Number of Pages | 124 |
Customization Available | Yes, the report can be customized as per your needs |
Ingesting of antibiotics per capita is growing on the backdrop of the increase in health care spending and out of concise medicinal spending. Low- and middle-income countries are growing in terms of per capita disposable income, and this factor is boosting antibiotic ingesting in these countries. Furthermore, favorable policies to push antibiotics in these countries have amplified the usage of antibiotics in some of these republics. Extreme usage of antibiotics by an individual results in inequity of microbiota, and also lowers the microbial variety as well as overall bacterial count in the gut.
Harmful effects of excess antibiotic consumption has been reported, necessitating the additional supplementation of friendly bacteria into the body. Some of these bacteria have also developed antibiotic resistant characteristics, and do not respond to the consumed antibiotics. It is thus important to replenish such bacteria in the body, thus nucleating beleaguered bacterial strain consumption. A larger chunk of such population relying on antibiotics has absorbed the importance of probiotic supplements, and have started consuming them.
What is the study period of this market?
The Global OTC Probiotics Supplement is studied from 2022-2027.
Who are the prime players in the Global OTC Probiotics Supplement?
Probiotics Market are Chr. Hansen Holding A/S, BioGaia AB, Probi AB, Nestlé S.A., DowDuPont Inc.
Which region held the largest share in the Global OTC Probiotics Supplement?
United States, Europe, China, Japan, Southeast Asia, India and Rest of World
What are the significant Types of Global OTC Probiotics Supplement?
Chewable & Gummies, Capsules, Powders, Tablets & Softgels, Others
What are the major Application of Global OTC Probiotics Supplement?
Infants, Children, Adults, Geriatric
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.